Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck - Multivariate analysis of prognostic factors and evaluation of therapeutic modalities -

T. Tomita, M. Fujii, Y. Imanishi, M. Kanke, J. Kanzaki, Y. Ohno, Y. Tokumaru, Y. Inuyama

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Prognostic factors and treatment outcome of 48 patients with Stage I (29) or II (19) non-Hodgkin's lymphoma of the head and neck were analyzed retrospectively. There were 26 males and 22 females, aged from 15 to 89 years old, with an average age of 57. The primary lesion was located in Waldeyer's ring in 25 patients, the nasal cavity and paranasal sinuses in 13, cervical lymph nodes in 8, and others in 2. Histologically, 2 had low grade lymphoma, 42 had intermediate grade disease, and 1 had high grade disease. The patients were treated with radiation alone (5 patients), chemotherapy according to a cyclophosphamide, doxorubicin, vincristine, predonisone-(CHOP) regimen (8 patients), or a combination of both treatments (35 patients). In univariate analyses, an unfavorable prognosis was associated with age≥60, Stage I disease, and extralymphatic lesion. Multivariate analysis showed that an extralymphatic lesion was a significant independent risk factor for death (p=0.0093). The overall five-year survival rate was 73.5%. Differences in the treatment was not reflected in the outcome. Our results suggest that a combination of chemotherapy (CHOP) and radiation is an appropriate treatment for lymphatic stage I and II non-Hodgkin's lymphoma of the head and neck. However, more intensive therapy is necessary for patients with extralymphatic head and neck NHL.

Original languageEnglish
Pages (from-to)809-817
Number of pages9
JournalJournal of Otolaryngology of Japan
Volume102
Issue number6
Publication statusPublished - 1999

Fingerprint

Non-Hodgkin's Lymphoma
Neck
Multivariate Analysis
Head
Paranasal Sinuses
Therapeutics
Radiation
Drug Therapy
Nasal Cavity
Vincristine
Combination Drug Therapy
Doxorubicin
Cyclophosphamide
Survival Rate
Lymph Nodes

Keywords

  • CHOP
  • Extralymphatic
  • Head and neck
  • Non-Hodgkin's lymphoma
  • Stage I or II

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck - Multivariate analysis of prognostic factors and evaluation of therapeutic modalities -. / Tomita, T.; Fujii, M.; Imanishi, Y.; Kanke, M.; Kanzaki, J.; Ohno, Y.; Tokumaru, Y.; Inuyama, Y.

In: Journal of Otolaryngology of Japan, Vol. 102, No. 6, 1999, p. 809-817.

Research output: Contribution to journalArticle

Tomita, T. ; Fujii, M. ; Imanishi, Y. ; Kanke, M. ; Kanzaki, J. ; Ohno, Y. ; Tokumaru, Y. ; Inuyama, Y. / Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck - Multivariate analysis of prognostic factors and evaluation of therapeutic modalities -. In: Journal of Otolaryngology of Japan. 1999 ; Vol. 102, No. 6. pp. 809-817.
@article{09a5418b81794974bcf91ef644abf831,
title = "Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck - Multivariate analysis of prognostic factors and evaluation of therapeutic modalities -",
abstract = "Prognostic factors and treatment outcome of 48 patients with Stage I (29) or II (19) non-Hodgkin's lymphoma of the head and neck were analyzed retrospectively. There were 26 males and 22 females, aged from 15 to 89 years old, with an average age of 57. The primary lesion was located in Waldeyer's ring in 25 patients, the nasal cavity and paranasal sinuses in 13, cervical lymph nodes in 8, and others in 2. Histologically, 2 had low grade lymphoma, 42 had intermediate grade disease, and 1 had high grade disease. The patients were treated with radiation alone (5 patients), chemotherapy according to a cyclophosphamide, doxorubicin, vincristine, predonisone-(CHOP) regimen (8 patients), or a combination of both treatments (35 patients). In univariate analyses, an unfavorable prognosis was associated with age≥60, Stage I disease, and extralymphatic lesion. Multivariate analysis showed that an extralymphatic lesion was a significant independent risk factor for death (p=0.0093). The overall five-year survival rate was 73.5{\%}. Differences in the treatment was not reflected in the outcome. Our results suggest that a combination of chemotherapy (CHOP) and radiation is an appropriate treatment for lymphatic stage I and II non-Hodgkin's lymphoma of the head and neck. However, more intensive therapy is necessary for patients with extralymphatic head and neck NHL.",
keywords = "CHOP, Extralymphatic, Head and neck, Non-Hodgkin's lymphoma, Stage I or II",
author = "T. Tomita and M. Fujii and Y. Imanishi and M. Kanke and J. Kanzaki and Y. Ohno and Y. Tokumaru and Y. Inuyama",
year = "1999",
language = "English",
volume = "102",
pages = "809--817",
journal = "Journal of Otolaryngology of Japan",
issn = "0030-6622",
publisher = "Oto-Rhino-Laryngological Society of Japan Inc.",
number = "6",

}

TY - JOUR

T1 - Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck - Multivariate analysis of prognostic factors and evaluation of therapeutic modalities -

AU - Tomita, T.

AU - Fujii, M.

AU - Imanishi, Y.

AU - Kanke, M.

AU - Kanzaki, J.

AU - Ohno, Y.

AU - Tokumaru, Y.

AU - Inuyama, Y.

PY - 1999

Y1 - 1999

N2 - Prognostic factors and treatment outcome of 48 patients with Stage I (29) or II (19) non-Hodgkin's lymphoma of the head and neck were analyzed retrospectively. There were 26 males and 22 females, aged from 15 to 89 years old, with an average age of 57. The primary lesion was located in Waldeyer's ring in 25 patients, the nasal cavity and paranasal sinuses in 13, cervical lymph nodes in 8, and others in 2. Histologically, 2 had low grade lymphoma, 42 had intermediate grade disease, and 1 had high grade disease. The patients were treated with radiation alone (5 patients), chemotherapy according to a cyclophosphamide, doxorubicin, vincristine, predonisone-(CHOP) regimen (8 patients), or a combination of both treatments (35 patients). In univariate analyses, an unfavorable prognosis was associated with age≥60, Stage I disease, and extralymphatic lesion. Multivariate analysis showed that an extralymphatic lesion was a significant independent risk factor for death (p=0.0093). The overall five-year survival rate was 73.5%. Differences in the treatment was not reflected in the outcome. Our results suggest that a combination of chemotherapy (CHOP) and radiation is an appropriate treatment for lymphatic stage I and II non-Hodgkin's lymphoma of the head and neck. However, more intensive therapy is necessary for patients with extralymphatic head and neck NHL.

AB - Prognostic factors and treatment outcome of 48 patients with Stage I (29) or II (19) non-Hodgkin's lymphoma of the head and neck were analyzed retrospectively. There were 26 males and 22 females, aged from 15 to 89 years old, with an average age of 57. The primary lesion was located in Waldeyer's ring in 25 patients, the nasal cavity and paranasal sinuses in 13, cervical lymph nodes in 8, and others in 2. Histologically, 2 had low grade lymphoma, 42 had intermediate grade disease, and 1 had high grade disease. The patients were treated with radiation alone (5 patients), chemotherapy according to a cyclophosphamide, doxorubicin, vincristine, predonisone-(CHOP) regimen (8 patients), or a combination of both treatments (35 patients). In univariate analyses, an unfavorable prognosis was associated with age≥60, Stage I disease, and extralymphatic lesion. Multivariate analysis showed that an extralymphatic lesion was a significant independent risk factor for death (p=0.0093). The overall five-year survival rate was 73.5%. Differences in the treatment was not reflected in the outcome. Our results suggest that a combination of chemotherapy (CHOP) and radiation is an appropriate treatment for lymphatic stage I and II non-Hodgkin's lymphoma of the head and neck. However, more intensive therapy is necessary for patients with extralymphatic head and neck NHL.

KW - CHOP

KW - Extralymphatic

KW - Head and neck

KW - Non-Hodgkin's lymphoma

KW - Stage I or II

UR - http://www.scopus.com/inward/record.url?scp=0032787946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032787946&partnerID=8YFLogxK

M3 - Article

VL - 102

SP - 809

EP - 817

JO - Journal of Otolaryngology of Japan

JF - Journal of Otolaryngology of Japan

SN - 0030-6622

IS - 6

ER -